WHO ICTRP trial
A clinical trial of CART cell therapy for refractory and relapsed B cell…
ChiCTR-ONC-16008405 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-ONC-16008405 |
|---|---|
| Public title | A clinical trial of CART cell therapy for refractory and relapsed B cell hematological maliganacies |
| Scientific title | A clinical trial of CART cell therapy for refractory and relapsed B cell hematological maliganacies |
| Primary sponsor | The first affiliated hospital of Xi'an Jiaotong university |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | refractory and relapsed B cell hematological maliganacies |
| Interventions | one:autologous CAR-Tcells |
| Registration date | May 2, 2016 |
| Target size | one:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: